402 related articles for article (PubMed ID: 29355568)
1. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function.
Oaks AW; Frankfurt M; Finkelstein DI; Sidhu A
PLoS One; 2013; 8(4):e60378. PubMed ID: 23560093
[TBL] [Abstract][Full Text] [Related]
3. Neuronal expression of familial Parkinson's disease A53T α-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice.
Rothman SM; Griffioen KJ; Vranis N; Ladenheim B; Cong WN; Cadet JL; Haran J; Martin B; Mattson MP
J Parkinsons Dis; 2013; 3(2):215-29. PubMed ID: 23938351
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
5. Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice.
Wu Q; Yang X; Zhang Y; Zhang L; Feng L
Exp Neurol; 2016 Nov; 285(Pt A):61-71. PubMed ID: 27637804
[TBL] [Abstract][Full Text] [Related]
6. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
[TBL] [Abstract][Full Text] [Related]
9. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system.
Noorian AR; Rha J; Annerino DM; Bernhard D; Taylor GM; Greene JG
Neurobiol Dis; 2012 Oct; 48(1):9-19. PubMed ID: 22722052
[TBL] [Abstract][Full Text] [Related]
11. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.
Paumier KL; Sukoff Rizzo SJ; Berger Z; Chen Y; Gonzales C; Kaftan E; Li L; Lotarski S; Monaghan M; Shen W; Stolyar P; Vasilyev D; Zaleska M; D Hirst W; Dunlop J
PLoS One; 2013; 8(8):e70274. PubMed ID: 23936403
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
Deusser J; Schmidt S; Ettle B; Plötz S; Huber S; Müller CP; Masliah E; Winkler J; Kohl Z
J Neurochem; 2015 Nov; 135(3):589-97. PubMed ID: 26201615
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.
Martin LJ; Pan Y; Price AC; Sterling W; Copeland NG; Jenkins NA; Price DL; Lee MK
J Neurosci; 2006 Jan; 26(1):41-50. PubMed ID: 16399671
[TBL] [Abstract][Full Text] [Related]
14. Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.
Mammadova N; Baron T; Verchère J; Greenlee JJ; Greenlee MHW
Methods Mol Biol; 2021; 2224():75-85. PubMed ID: 33606207
[TBL] [Abstract][Full Text] [Related]
15. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
[TBL] [Abstract][Full Text] [Related]
16. DNA damage preceding dopamine neuron degeneration in A53T human α-synuclein transgenic mice.
Wang D; Yu T; Liu Y; Yan J; Guo Y; Jing Y; Yang X; Song Y; Tian Y
Biochem Biophys Res Commun; 2016 Dec; 481(1-2):104-110. PubMed ID: 27818201
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
[TBL] [Abstract][Full Text] [Related]
18. Early Parkinson's disease symptoms in α-synuclein transgenic monkeys.
Niu Y; Guo X; Chen Y; Wang CE; Gao J; Yang W; Kang Y; Si W; Wang H; Yang SH; Li S; Ji W; Li XJ
Hum Mol Genet; 2015 Apr; 24(8):2308-17. PubMed ID: 25552648
[TBL] [Abstract][Full Text] [Related]
19. Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model.
Flores-Cuadrado A; Saiz-Sanchez D; Mohedano-Moriano A; Martinez-Marcos A; Ubeda-Bañon I
Acta Neuropathol Commun; 2019 Apr; 7(1):56. PubMed ID: 30987677
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress.
Kim S; Park JM; Moon J; Choi HJ
Exp Neurol; 2014 Feb; 252():63-74. PubMed ID: 24252179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
